Design and evaluation of Lumefantrine – Oleic acid self nanoemulsifying ionic complex for enhanced dissolution

[1]  P. Vavia,et al.  Design and evaluation of Lumefantrine – Oleic acid self nanoemulsifying ionic complex for enhanced dissolution , 2013, DARU Journal of Pharmaceutical Sciences.

[2]  F. Ahmad,et al.  Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique. , 2012, Colloids and surfaces. B, Biointerfaces.

[3]  Ketan Patel,et al.  Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design , 2012, AAPS PharmSciTech.

[4]  P. Vavia,et al.  Rice Germ Oil as Multifunctional Excipient in Preparation of Self-Microemulsifying Drug Delivery System (SMEDDS) of Tacrolimus , 2012, AAPS PharmSciTech.

[5]  J. Ayyappan,et al.  Development and Validation of a Dissolution Test Method for Artemether and Lumefantrine in Tablets , 2011 .

[6]  S. Puri,et al.  Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats , 2011, Malaria Journal.

[7]  T. Adak,et al.  Knockdown resistance (kdr)-like mutations in the voltage-gated sodium channel of a malaria vector Anopheles stephensi and PCR assays for their detection , 2011, Malaria Journal.

[8]  R. Dhumal,et al.  Rheological investigation of self-emulsification process: effect of co-surfactant. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[9]  G. Edwards,et al.  Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. , 2008, Journal of pharmaceutical sciences.

[10]  Ashok R. Patel,et al.  Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate , 2007, The AAPS Journal.

[11]  S. Stegemann,et al.  When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  Pratap Singhasivanon,et al.  How much fat is necessary to optimize lumefantrine oral bioavailability? , 2007, Tropical medicine & international health : TM & IH.

[13]  A. Date,et al.  Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. , 2007, International journal of pharmaceutics.

[14]  Shobha Bhattachar,et al.  The road map to oral bioavailability: an industrial perspective , 2006, Expert opinion on drug metabolism & toxicology.

[15]  A. Adegoke,et al.  Determination of physicochemical properties of halofantrine. , 2003, African journal of medicine and medical sciences.

[16]  D. Shah,et al.  Spontaneous Emulsification: Mechanisms, Physicochemical Aspects, Modeling, and Applications , 2002 .

[17]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[18]  J. Karbwang,et al.  Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. , 1998, British journal of clinical pharmacology.